Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)

US National Institutes of Health (NIH) grant open #PAR-25-193

Response due Sep 07, 2026 · 00:00 UTC

Summary

The National Institutes of Health (NIH) is soliciting R34 clinical trial planning grant applications focused on alcohol treatment, pharmacotherapy, and recovery research. This opportunity requires a clinical trial component and is intended to support the planning and development stages of research addressing alcohol use disorder treatment and recovery. The R34 mechanism is a milestone-driven grant designed to fund preliminary work necessary to plan a future clinical trial.

What they want

Technical requirements

Clinical trial component is required
Must follow NIH R34 clinical trial planning grant mechanism
Milestone-driven research planning structure required

How they evaluate

Submission: Electronic submission via Grants.gov federal grants portal

Risks & flags

No dollar value or budget ceiling stated — difficult to assess competitiveness without funding cap details
Long open window (Nov 2024 – Sep 2026) with multiple submission cycles typical of NIH PARs — not inherently suspicious but warrants tracking of specific due dates within the FOA

Market context

inferred from NAICS

Professional, Scientific & Technical Services

NAICS 541711

US market size: $2.0T
Typical award: $25K – $50M

Typical buyers

All federal civilianDoDStates

Commonly required

8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

Alcohol Treatment, Pharmacotherapy, and Re…

Due Sep 07

Onboard ↗